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ABSTRACT
￿
We have devised a procedure for the identification of individual molecules which
are associated with the mitotic spindle apparatus and cytoskeleton in mammalian cells. We
prepared monoclonal antibody-producing hybridomas by immunizing mice with mitotic
spindles isolated from cultured HeLa cells. Among several antibody-producing clones ob-
tained, one hybridoma (22MA2) produced an antibody that recognizes a putative microtubule-
associated protein which exhibits unusual distribution characteristics in cultured cells. Immu-
nofluorescence studies showed that during mitosis the 22MA2 antigen is distributed in parallel
with the spindle fibers of the mitotic apparatus, and that during interphase the antigen is
always associated to a limited extent with cytoplasmic microtubules. Also, the co-distribution
of the antigen with microtubules was found to be Colcemid sensitive. However, the 22MA2
antibody immunofluorescently stained the nuclei of cells in the exponential growth phase,
but did not stain the nuclei of cells that had grown to confluence. This nuclear fluorescence
appears to be directly related to cell density rather than nutritional (serum) factors in the
growth medium . The results suggest that the antigen undergoes some change in structure or
distribution in response to changes in the proliferative capacity of the cell . Biochemical
analyses of cytoplasmic, nuclear, and mitotic spindle subcellular fractions show that the
antigen exhibits a polypeptide molecular weight of 240,000, is found in various mammalian
cells ranging from marsupial to human, and is particularly susceptible to proteolysis.
Microtubules constitute a major portion of the interphase
cytoskeleton and the mitotic spindle fibers in eucaryotic cells.
It is now commonly recognized that microtubule protein
subunits (tubulin) can be induced in vitro to undergo polym-
erization and depolymerization in response to a variety of
stimuli. However, the endogenous factors that control micro-
tubule assembly and disassembly in vivo remain largely un-
known. Much ofthe recent work in this fieldhas been directed
toward elucidating the cellular factors that control microtu-
bule functions.
Evidence has accumulated that proteins other than tubulin
are responsible for the cellular control of microtubule assem-
bly and disassembly. Workers have identified several micro-
tubule-associated proteins (MAPs)' by taking advantage of
'Abbreviations used in this paper:
￿
BHK-21, baby hamster kidney;
DME, Dulbecco's modified Eagle's medium; FCS, fetal calf serum;
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the fact that some proteins are found associated with micro-
tubules purified from cell extracts by cycles of assembly and
disassembly. Using this approach, investigators have found
MAPS in isolates from brain tissue (8, 20, 22, 36) as well as
from cultured cells (4, 7, 23, 24, 33, 37).
Because brain is composed largely of differentiated tissue,
much work has recently been focused on the MAP composi-
tion of proliferating cultured cells. The most extensive cata-
logue of non-neural MAPS to date has been made using
microtubule proteins isolated by the assembly/disassembly
method from cultured HeLa cell extracts. Studies have shown
that this type ofpreparation, when analyzed using SDS PAGE,
contains MAPs with molecular weights grouped in the ranges
of 200,000-220,000 and 97,000-125,000 (4, 33), with some
MAP, microtubule-associated protein; MEM, Eagle's minimal essen-
tial medium; PMSF, phenylmethylsulfonyl fluoride.
503minor components detected at
￿
250,000 (4, 33) and 68,000
(33). Immunocytochemical studies on cultured cells have
shown that several ofthese HeLa MAP species are associated
with the general cellular microtubule population(5, 13), while
another study presented evidence that one MAP species of
the 200,000-mol-wt cluster is specifically associated with the
mitotic apparatus and the interphase nucleus (12).
The aforementioned studies have approached the identifi-
cation of MAPS by the initial selection for those proteins that
co-assemble with microtubules in vitro. While this is clearly
a technically useful criterion, other investigators have pointed
out that co-assembly in vitro is not an absolute prerequisite
for determining whether or not a protein can be considered a
MAP in vivo (17, 30, 33). Also, the in vitro section for MAPS
that co-assemble with microtubules could exclude proteins
that may nevertheless be integral to microtubule functions in
the cell.
Our interest in identifying and characterizing nontubulin
components of the mammalian mitotic spindle has led us to
a slightly different approach to the problem. It is difficult to
isolate mitotic spindles from cultured cells (or any other
mammalian cells) in sufficiently pure quantities for biochem-
ical analyses of discrete protein components. However, we
reasoned that if enough spindles could be isolated for use as
crude antigens to elicit an immunological response in mice,
hybridomas couldbe produced that might secrete monoclonal
antibodies against nontubulin components of the mitotic
apparatus. In this report we describe the production of such
an antibody, as well as its use in the initial characterization
ofan unusual microtubule-associated protein.
MATERIALS AND METHODS
Cell Culture:
￿
The cell lines PtK2 (rat kangaroo kidney epithelium),
BRL-3A (rat liver epithelium), 3173 (mouse embryonic fibroblast), BHK-21
(hamster kidney fibroblast), R9ab (rabbit lung fibroblast), Chinese hamster
ovary, HeLa (human cervical carcinoma), and WI-38 (human lung fibroblast)
were all obtained from the American Type Culture Collection, Rockville, MD.
The mouse plasmacytoma (myeloma) line NS- I was originally obtained from
the Salk Institute Cell Distribution Center, San Diego, CA. PtK2, BRL-3A,
BHK-21, R9ab, Chinese hamster ovary, HeLa, and WI-38 cultures were grown
in Eagle's minimal essential medium (MEM) supplemented with Earle's salts
and 10% fetal calf serum (FCS). 3173 and NS-I cultures were grown in
Dulbecco's modified Eagle's medium (DME) containing 10% FCS. Established
hybridoma clones (see below) were grown in DME containing 10% HyClone
FCS (Sterile Systems, Inc., Logan, UT). All cultures were maintained at 37°C
in a humidified atmosphere of 5% C02 (for cultures in MEM) or 7.5% CO2
(for cultures in DME).
Mitotic Spindle Isolation:
￿
HeLa cells were grown (as monolayers)
to 50% confluence in large T-flasks, and were partiallysynchronizedby a single
excess thymidine block (2). After removal ofthe thymidine blockade, cells were
allowed to progress into mitosis where they were arrested by the addition of 1.3
x 10' M nocodazole to the growth medium (38). Mitotic cells were allowed
to accumulate for 3-5 h in the presence of nocodazole before they were
harvested by vigorously shaking the flasks. The cells were then pelleted by
centrifugation, washed once with fresh medium, and resuspended in drug-free
medium at 37°C. More than 90% of the cells formed metaphase spindles (as
determined by phase-contrast microscopy) after a 30-min recovery from the
effects ofthe nocodazole.
Mitotic spindles were isolated from the synchronized mitotic cells using
modifications of the method of Chu and Sisken (6), and all procedures were
performed at 37°C. After removal of the medium by centrifugation, the cells
were washed twice with PBS. Cell pellets were then resuspended in 50 vol of
swelling buffer (t mM sodium phosphate, 1 M hexylene glycol, pH 6.5) and
centrifuged at 500 g for 3 min. Swelling buffer was removed, the pellets of
swollen cells were resuspended in 10-20 vol of lysing buffer (1 mM sodium
phosphate, 1 M hexylene glycol, 0.25% Triton X-100, 1 mM EGTA, pH 6.5),
and the cells were disrupted by vigorous vortexing for -20 s. The lysates were
monitored by phase-contrast microscopy for the presence of intact metaphase
spindles free ofcytoplasmic debris. Preparations were further used only ifthey
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contained ?95% spindles (with the remaining <_5% consisting of unbroken
cells and/or nuclei). We quantitated spindles by examining lysate samples in a
hemacytometer with a phase-contrast microscope. Lysates were then chilled to
4°C and the mitotic spindles were pelleted by centrifugation at 800 g for 10
min. After removal of the supernatant, spindles were washed once with lysing
bufferandeitherstored as frozen pellets or processedfor electrophoreticanalysis
(see below).
Monoclonal Antibody Production:
￿
BALB/c or CB6FI/j mice
were immunized intraperitoneally with 1-2 x 10' HeLa spindles emulsified in
Freund's complete adjuvant. The mice were boosted 2-4 wk later with the
same number ofspindles emulsified in Freund's incomplete adjuvant. 4 d later
the animals were killed, spleens were removed and dissociated, and the spleen-
ocytes were fused with NS-1 myeloma cells (at a 5:1 ratio of spleenocytes/
myeloma cells) according to the general procedures of Kohlerand Milstein (15)
as modified by Kennett (14). Fused cells were resuspended in hypoxanthine/
aminopterin/thymidine-selective DME (l9) and distributed into four 24-well
culture plates for each spleen equivalent of fused cells.
When hybridoma cultures achieved 60% confluence, their culture superna-
tants were assayed by immunofluorescence as follows. PtK cells were inocu-
lated into 24-well culture plates containing a sterile round 6-mm coverslip in
each well, and were allowed to grow to 60-70% confluence. Growth medium
was removed and coverslip cultures were fixed with 3.7% formaldehyde in PBS,
followed by three washes with PBS containing 0.05% Triton X-100. Individual
wells containing fixed coverslip cultures then received samples of growth
medium from individual hybridoma culture wells described above. After in-
cubation with hybridoma supernatants for 2 h at 37°C, the coverslip cultures
were washed three times with PBS (5 min each) and then incubated with a
1:100 dilution (in PBS) of fluorescein-conjugated goat anti-mouse Igs (Anti-
bodies, Inc., Davis, CA) at 37°C for 30 min. Coverslips were then washed three
times with PBS, removed from the assay wells, and mounted with Aquamount
(Lerner Labs, New Haven, CT). Coverslips were examined by fluorescence
microscopy for mitotic cells that showed positively stained mitotic spindles.
Hybridomas found by the assay to secrete the desired antibodies were harvested
and cloned at least twice by limiting dilution. The hybridoma clones were then
grown up in flasks, and their culture supernatants were harvested and used as
the source of monoclonal antibodies for subsequent experiments.
General Immunofluorescence Procedures:
￿
Cells were grown
as monolayers on sterile 11 x 22 mm coverslips in 60-mm culture dishes.
Coverslip cultures were briefly rinsed with PBS and usually fixed with 3.7%
formaldehyde in PBS for 20 min at 23°C. In some experiments, fixation
methods using glutaraldehyde (35) or cold methanol (25) were used for com-
parison with the formaldehyde procedure. The cells were then washed once
with PBS containing 0.05% Triton X-100 and twice with PBS alone, followed
by a l-h incubation with the appropriate primary antibody at 37°C. Primary
antibodies included hybridoma supernatants containing mouse monoclonal
antibody (described above, undiluted) or rabbit antibody directed against
tubulin (prepared by the method of Fuller et al. [10]) diluted 1 :20 in PBS.
Controls included preimmune mouse and rabbit seradiluted in PBS. Cells were
then freed ofexcess primary antibody by three washes with PBS and incubated
with the appropriate fluorescently labeled secondary antibody for 30 min at
37°C. Secondary antibodies were diluted 1 :100 in PBS and included fluorescein-
conjugated goat anti-mouse IgG + IgM (Boehringer Mannheim Biochemicals,
Indianapolis, IN) or rhodamine-conjugated goat anti-rabbit IgG (U. S. Bio-
chemicalCorp., Cleveland, OH). Following fluorescent labeling, coverslips were
washed three times with PBS, rinsed with distilled water, and mounted with
Aquamount for observation. Coverslips were examined with a Zeiss epifluores-
cence microscope equipped with the appropriate excitation filters (Zeiss filter
set No. 487709 for fluorescein and set No. 487714 for rhodamine). Fluorescent
images were recorded on Kodak Tri-X Pan film using 1-min exposures for all
photomicrographs.
Preparation of Cell Extracts and Subcellular Fractions:
￿
Cells
exponentially growing in 150-mm tissue culture dishes were harvested with a
rubber policeman and washed three times with PBS. All subsequent operations
were carried out at 4°C unless otherwise noted. For whole-cell extracts, cell
pellets were resuspended directly in electrophoresis sample buffer (16). For
cytoplasmic and nuclear fractions, cells were resuspended in PBS containing
0.25% Triton X-100 and disrupted with two to three strokes in a Dounce
homogenizer, and the nuclei were pelleted by centrifugation. The resulting
supernatant (cytoplasmic fraction) was removed and combined with an equal
volume of 2X sample buffer. The pelleted nuclei were either stored frozen or
resuspended in sample buffer. The effect of protease inhibitors was tested by
using one ofthe following compounds (all obtained from Sigma Chemical Co.,
St. Louis, MO) in all extraction buffers: aprotinin (100 KIU/ml); phenylmeth-
ylsulfonyl fluoride (PMSF, 0.1 mM); pepstatin A (10 pct); or leupeptin (l0
,act). In some experiments the isolations were carried out at 23°C with or
without protease inhibitors in the extraction buffers, and the isolates were either
stored under various conditions or were used immediately in electrophoreticanalyses . Protein concentrations were estimated using the Schacterle and Pol-
lack (28) modification of the method ofLowry et al. (21) .
Electrophoretic Procedures:
￿
Before electrophoresis, all extracts
were sonicated in sample buffer containing 0.0625 M Tris-HCI, 2% SDS, 5
mM dithiothreitol, 1 mM EDTA, 10% glycerol, and 0.001% bromophenolblue
as tracking dye . Samples were then boiled for 2 min and analyzed by SDS
PAGE (16) using 0.75-mm thick slab gels. Prestained molecular weight stand-
ards (Bethesda Research Labs, Gaithersburg, MD) were run in every gel and
included myosin heavy chain (200,000 mol wt), phosphorylase b (92,500), BSA
(68,000), and ovalbumin (43,000) . Additional molecular weight standards
included MAP-I (340,000 mol wt), MAP-2 (280,000), and tubulin (55,000) .
Duplicate sets ofsamples were electrophoresed in each gel . Following electro-
phoresis each gel was cut in halfand one halfwas fixed, stained, and destained
with Coomassie Blue according to Fairbanks et al. (9). The other half was
subjected to electrophoretic transfer of the protein patterns (Western blotting)
onto nitrocellulose membrane using the method of Towbin et al . (31), except
that the nitrocellulose sheet was sandwiched on the anodal side of the gel .
Transfer efficiencies were determined by Coomassie Blue-staining the trans-
ferred gels and densitometrically comparing them with the duplicate samples
run in the nontransferred halves ofthe gels . Transfer efficiencies were typically
?93% for proteins below 170,000 mol wt and ?65% for those above that
molecular weight. It was also found that the prestained molecular weight
standards efficiently transferredonto the nitrocellulose, whichgreatly simplified
calibrations ofthe Western blots.
Antibody Staining of Western Blots:
￿
All procedureswere carried
out at 37°C unless otherwise noted . After electrophoretic transfer (see above),
Western blots were incubated for 30 min in PBS containing 3% BSA to block
remainingprotein binding sites on the nitrocellulose. Blotswere then incubated
with the following sequence of reagents for 30 min each : (a) hybridoma
supernatant (containing mouse monoclonal antibody) diluted 1 :1 with 3% BSA
in PBS; (b) biotinylated horse anti-mouse Igs (Vector Labs, Burlingame, CA)
diluted 1 :200 with 1.5% BSA in PBS; and (c) peroxidase-conjugated avidin
(Vector Labs) diluted 1 :100 with 1.5% BSA in PBS. All reagent incubations
were carved out by overlaying each Western blot with a sheet ofWhatman No.
1 filter paper cut to size and saturated with reagent at 25 gel/cm' of filter paper.
After each reagent incubation the blots were washed twice at 23°C with PBS
containing 0.05% Triton X-100 and then twice with PBS alone. To visualize
the sites of peroxidase antibody bound to antigen, we incubated the blots 7
min at 23°C in PBS containing0.005% 4-chloro-l-naphthol and 0.001% H202.
The blots were rinsed with distilled water after color development and were
air-dried .
RESULTS
HeLa mitotic apparatuses were obtained by disrupting syn-
chronized metaphase cells in a buffer that stabilizes the struc-
ture of mitotic spindles (see Materials and Methods and
reference 6) . As reported by other investigators, the isolated
spindles are cold stable and free of chromosomes (presumably
owing to the effects of the hexylene glycol and the hypotonic
nature of the buffer, respectively). Spindles can be obtained
relatively free of cytoplasmic debris (Fig . 1), and a typical
preparation from 4 x T-175 cm' flasks of cells usually yields
approximately 1-2 x 10 7 spindles. The isolated spindles are
only moderately immunogenic when injected into mice . Of
26 cell fusions carried out using spleenocytes of mice immu-
nized with spindles, 41 hybridoma culture wells were initially
found by immunofluorescence to contain antibodies that
recognized microtubules and/or spindle components in fixed
PtK2 cells .The use ofPtK2 cells in immunofluorescence assays
facilitated the observation of intracellular structures because
they remain flat and well attached to the substrate during the
cell cycle, including mitosis. Further analyses revealed that
-80% of the antibodies were antitubulins .
Among several interestinghybridoma clones obtained using
these procedures, one (22MA2 .1 .1, hereafter designated
22MA2) was selected for use in the present study. The anti-
body was found to be of the IgM subclass by Ouchterlony
double immunodiffusion of22MA2 hybridoma supernatant
against goat antibodies prepared against specific subclasses of
mouse immunoglobulins . In this report we describe the use
FIGURE 1 Phase-contrast micrograph of isolated HeLa spindles.
Bar, 20 ,um . x 450.
of the 22MA2 monoclonal antibody for the characterization
of its antigen with respect to its intracellular distribution and
some of its physical properties .
Intracellular Localization of the 22MA2 Antigen
by Immunofluorescence
The immunofluorescence distribution of both tubulin and
the 22MA2 antigen in the same interphase PtK 2 cell is shown
in Fig . 2 . The rhodamine-labeled rabbit antitubulin fluores-
cence pattern (Fig . 2 a) shows a positively stained cytoplasmic
microtubule complex, which is in agreement with previous
reports (3, 34) . The fluorescein-labeled 22MA2 antibody dis-
tribution (Fig. 26) is co-localized with cytoplasmic microtu-
bules, although with a lesser degree of antibody staining
intensity . This relatively attenuated amount of22MA2 stain-
ing of cytoplasmic microtubules (as compared with that of
antitubulin) was consistently observed in this and all other
immunofluorescence assays using the monoclonal antibody.
Fig. 2 also shows that the 22MA2 antibody intensely stains
the interphase nuclei of cells. The 22MA2 fluorescence is
sharply defined by the nuclear envelope, and its intranuclear
distribution appears homogeneous when examined by focus-
ing through the nucleus . Fixed cells incubated with rabbit and
mouse preimmune control sera (followed by incubation with
rhodamine anti-rabbit IgG and fluorescein anti-mouse IgG +
IgM, respectively) are shown in Fig . 2, c and d, and are
negative.
The immunofluorescence staining pattern of the 22MA2
antibody during mitotic stages is shown in Fig . 3 . At prophase
(Fig. 3 a) the 22MA2 labeling remains within the nucleus and
is distributed throughout the nucleoplasm, in contrast to the
condensing prophase chromatin . Some staining is seen asso-
ciated with the separating centrosomes, and a relatively small
amount is associated with the microtubules radiating from
the centrosomes . Fig . 3 6 shows that at prometaphase, upon
breakdown ofthe nuclearenvelope, the newly forming spindle
microtubules are intensely stained with the antibody. This
abundance ofspindle fiber staining with the 22MA2 antibody
persists through metaphase (Fig. 3c) and anaphase when, in
addition, staining of the continuous microtubules between
the separating chromosomes can be seen (Fig. 3d) . At telo-
phase (Fig . 3 e) the antibody stains the spindle remnants
contained in the midbody, and the newly forming telophase
nuclei show that the material recognized by the antibody is
sequestered within the nucleus at this stage . Fig . 3fshows the
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Double-label immunofluorescence pattern of antitubulin and 22MA2 monoclonal antibody staining in the same cell .
PtK2 cells were fixed and incubated with 22MA2 antibody followed by fluorescein goat anti-mouse IgG + IgM and then rabbit
antitubulin followed by rhodamine goat anti-rabbit IgG . Photomicrographs were then taken at 1-min exposures using (a) rhodamine
excitation for antitubulin and (b) fluorescein excitation for 22MA2 monoclonal antibody . (c) Preimmune rabbit serum control and
(d) preimmune mouse serum control, both performed as described in the text . Bars, 20 ,m . (a and b) x 460 ; (c and d) x 730 .
FIGURE 3 Immunofluorescence distribution of the 22MA2 antibody during mitosis. PtK 2 cells were processed for 22MA2
immunofluorescence as described in Materials and Methods . (a) Prophase cell ; (b) prometaphase cell ; (c) metaphase cell ; (d)
anaphase cell ; (e) telophase cell . (f) PtK 2 cells treated with 1 .3 x 10-7 M colcemid for 1 h at 37°C followed by fixation and
processing for 22MA2 immunofluorescence . Bar, 20 Am . x 460 .
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body in different cell types . Various cell types were fixed and
processed for 22MA2 immunofluorescence as described . (a) BRL-
3A (rat epithelium) cells ; (b) BHK-21 (hamster fibroblast) cells ; (c)
WI-38 (human fibroblast) cells ; (d) HeLa (human carcinoma) cells.
Bar, 20 um . x 550 .
22MA2 fluorescence distribution in cells treated with col-
cemid. It can be seen that the spindle fiber staining is sensitive
to colcemid in a manner similar to that of microtubules .
Fig . 4 shows the subcellular distribution of22MA2 immu-
nofluorescence in various cultured cell species. Interphase rat,
hamster, and human cells all show the same general immu-
nofluorescence pattern as that described above for PtK2. Fig .
4 a shows a metaphase BRL-3A cell whose mitotic spindle is
positively stained with the 22MA2 antibody . The positive
spindle staining was observed in the mitotic cells of all other
species studied as well (micrographs not shown) .
22MA2 Immunofluorescence Using Different
Fixation Procedures
Because the 22MA2 antigen displays an unusual pattern of
intracellular distribution, we decided to examine its immu-
nofluorescence pattern in cells fixed using different methods.
This was done in an attempt to determine whether the routine
formaldehyde fixation used in the experiments shown in Figs .
2-4 could lead to an artifactual association of the 22MA2
antibody and/or antigen with nuclei and microtubules. PtK2
cells were fixed by two additional methods ; (a) cells were
fixed with glutaraldehyde followed by borohydride treatment
according to Weber et al . (35) or (b) cells were fixed using
cold (-20°C) methanol (25) . After fixation, cells were proc-
essed for immunofluorescence with the 22MA2 antibody in
the usual manner .
Fig. 5 shows that both glutaraldehyde (Fig. 5a) and meth-
anol (Fig. 5b) fixations result in positively stained spindles
and nuclei using the 22MA2 antibody . However, methanol
fixation gives poor preservation of cytoplasmic microtubule
staining and results in the severe extraction of nuclei which
show only a residual speckled appearance .
Biochemical Analyses of the 22MA2 Antigen
Electrophoretic analyses were undertaken in an attempt to
identify the polypeptide molecular weight of the 22MA2
antigen and correlate its distribution in subcellular fractions
with the results of the immunofluorescence studies described
above. Crude HeLa proteins from whole cells, cytoplasm,
nuclei, and mitotic apparatuses were prepared and analyzed
with SDS PAGE as described in Materials and Methods .
Electrophoretic transfers (Western blots) were prepared from
the gels and were immunochemically probed with the 22MA2
monoclonal antibody .
Fig . 6 shows that the antibody recognizes a single polypep-
tide band which exhibits a molecular weight of 240,000 . (In
other experiments [not shown] 12.5% polyacrylamide gels
FIGURE 5 22MA2 immunofluorescence staining pattern in PtK2
cells using different fixation procedures . Cells were fixed with either
(a) glutaraldehyde or (b) cold methanol as described in Materials
and Methods and processed for 22MA2 immunofluorescence . Bars,
20 um . (a) x 460 ; (b) x 660 .
FIGURE 6
￿
Immunochemical analysis of 22MA2 antigen distribution
in HeLa subcellular extracts . HeLa whole cells or subcellular extracts
were prepared and analyzed by SDS PAGE using an 8% polyacryl-
amide gel . Duplicate SDS PAGE protein patterns were then either
fixed and stained with Coomassie Blue (lanes A-D) or electropho-
retically transferred onto nitrocellulose and immunochemically ana-
lyzed with the 22MA2 antibody (lanes A'-D') as described in
Materials and Methods . (A, A') Whole HeLa cells, 50 jug ; (B, B')
HeLa cytoplasmic fraction, 50 ug ; (C, C') HeLa nuclear fraction, 50
jug; (D, D') HeLa mitotic spindles, 20 ug. Numbers on the left side
refer to the electrophoretic migration of molelcular weight stand-
ards (K, 1,000) : MAP-1 (340,000); MAP-2 (280,000) ; myosin heavy
chain (200,000) ; phosphorylase b (92,500) ; BSA (68,000) ; tubulín
(55,000); ovalbumin (43,000) . The arrowhead denotes the position
of the 22MA2 antigen .
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22MA2 antibody recognizes any lower molecular weight com-
ponents [>_ 10,000 mol wt], and none were detected .) The
protein loads of each of the crude extracts in lanes A', B',
and C' were roughly equivalent at 50 kg each, and two sets
of the samples were run on the same gel . One set was cut
from the gel and stained with Coomassie Blue (lanes A, B,
and C), while the other set of samples was electrophoretically
transferred onto the same sheet of nitrocellulose and simul-
taneously probed with the antibody (lanes A', B', and C',
respectively) . Therefore the relative antibody staining inten-
sity of the bands should correspond to the quantity ofantigen
present as a relative percentage of the total protein in the
samples . Using this as a frame of reference, we found that the
relative amounts of antigen present in the cytoplasmic and
nuclear fractions (lanes B' and C', respectively) correspond
well with the results of the immunofluorescence studies de-
scribed above . It should be noted that the bands recognized
by the 22MA2 antibody in the nuclear (lane C') and mitotic
apparatus (lane D') fractions co-migrate at 240,000 mol wt.
Similar analyses were performed using whole-cell extracts
from several species ofcultured cells, and the resultsare shown
in Fig . 7 . In addition, rabbit brain microtubule protein (iso-
lated by two cycles of assembly/disassembly according to
Borisy et al . [1] and kindly provided by Dr . Lou Morejohn,
University of California, Irvine) was analyzed to determine
any cross-reactivity of the 22MA2 antibody with the high
molecular weight neural MAPS . The polypeptide recognized
by the 22MA2 antibody exhibits a molecular weight of
240,000 in various species ranging from marsupial to human .
Fig. 7 (lanesE and E') also shows that the 22MA2 antibody
does not cross-react with brain tubulin or the high molecular
weight MAPs using the Western blot procedure .
In several initial experiments of the type described imme-
diately above, the antibody detected a single polypeptide with
a molecular weight of 115,000 (26) . These electrophoretic
analyses were performed using nuclei or mitotic spindles that
were isolated in the presence of the protease inhibitor apro-
FIGURE 7
￿
Immunochemical analysis of 22MA2 antigen in various
cell species . Whole cell extracts were prepared from different cell
types and analyzed by SDS PAGE using a 6.5% polyacrylamide gel .
Duplicate electrophoresed samples were then either stained with
Coomassie Blue (lanes A-D) or electrophoretically transferred onto
nitrocellulose and analyzed with the 22MA2 antibody (lanes A'-
D') . (A, A') PtK Z extract, 40 ug; (B, B') 3T3 extract, 40 ug ; (C, C')
rabbit fibroblast extract, 40 ug; (D, D') WI-38 extract, 40 ug; (E, E')
rabbit brain microtubule protein, 10 ug. Markers on the left refer to
molecular weight standards as in Fig. 6 . The arrowhead denotes the
position of the 22MA2 antigen .
508
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 99, 1984
FIGURE 8
￿
Effects of protease inhibitors on the preservation of the
22MA2 antigen in cell extracts . HeLa cells were disrupted and the
nuclei were isolated in the presence of (A, A') aprotinin ; (B, B')
PMSF ; (C, C') pepstatin A + leupeptin ; or (D, D') no inhibitor, as
described in the text. Duplicate samples (all 50 ug) were analyzed
by SDS PAGE (7.5% gel) and either Coomassie Blue-stained (lanes
A-D) or electrophoretically transferred onto nitrocellulose and
probed with the 22MA2 antibody (lanes A'-D') . Markers on the left
refer to molecular weight standards as in Fig. 6 . The arrowhead
denotes the position of the 22MA2 antigen .
tinin (see Materials and Methods) and had been stored at
either 4° or -20°C in their respective isolation buffers for 1-
5 d prior to electrophoretic analysis . Later experiments using
samples that were freshly isolated and immediately electro-
phoresed showed the appearance ofthe 240,000-mol-wt poly-
peptide . Therefore we attempted to examine the effectiveness
of other protease inhibitors in preventing the degradation of
the 240,000-mol-wt antigen during the isolations . The results
of such an experiment are shown in Fig. 8 . This figure shows
the SDSPAGE and Western blot antibody analysis of extracts
prepared from HeLa cells in the presence (and absence) of
several protease inhibitors . We accelerated any proteolysis
that occurred during extractions by allowing the extracts to
stand for 2 h at 23°C before boiling them in electrophoresis
sample buffer . Subsequent analysis showed that considerable
proteolysis of the 240,000-mol-wt antigen occurs even in the
presence of aprotinin, PMSF, and pepstatin A + leupeptin
(Fig . 8, lanes A', B', and C', respectively) . Several discrete
proteolysic fragments of the 240,000-mol-wt antigen are rec-
ognized by the 22MA2 antibody, and occur at molecular
weights of - 115,000 and 95,000, and a cluster at 68,000 .
Also, lane D' of this figure shows that almost no antigen is
preserved when extracts are prepared in the absence of any
protease inhibitors . Comparisons of Fig . 8 lanes A'-D' show
that protease inhibitors do contribute to the preservation of
the 240,000-mol-wt antigen, and, in decreasing order of rela-
tive effectiveness, are aprotinin > PMSF > pepstatin A +
leupeptin > none. We must therefore conclude that the
115,000-mol-wt peptide detected in previous experiments was
a discrete proteolysic fragment ofthe 240,000-mol-wt antigen,
and occurred upon cold storage of extracts even in the pres-
ence of aprotinin . MAPs have been observed to be susceptible
to proteolysis (29, 33), and the 240,000-mol-wt antigen, as a
putative MAP, appears to be no exception . Therefore in all
subsequent experiments (such as those previously shown in
Figs . 6 and 7), extracts were prepared using a combination ofOur early immunofluorescence studies using the 22MÁ2
antibody occasionally showed stained cells that were negative
with respect to the nuclear fluorescence described in Figs . 2-
4 above.Upon reexamination ofthese specimens, we observed
that the coverslip cultures used in those studies had been
allowed to overgrow before fixation . This suggested that the
22MÁ2 antigen might no longer be present in nuclei of cells
that either had reached plateau phase in response to conflu-
ence (were no longer dividing) or had depleted the culture
medium . Immunofluorescence experiments were then carried
out to determine which of these two conditions might result
in the absence of nuclear fluorescence with the 22MÁ2 anti-
body .
PtK2 and BHK-21 cells were plated on coverslips either (a)
at high initial density (100% confluence) in fresh MEM
containing 10% FCS and were incubated for 24-36 h, or (b)
at low density (<_25% confluence) in MEM containing 0 .1
FCS and were . incubated for 48-72 h. Coverslips were then
fixed and processed for 22MÁ2 immunofluorescence in the
usual manner . The results of these experiments are shown in
Fig. 9 . Fig. 9, a and b clearly indicates that in 100% confluent
cells, although the slight staining of the cytoplasmic microtu-
bules remains, the nuclei are devoid of any staining with the
antibody (compare with Figs . 2-5) . Immediately prior to
fixation, parallel coverslip cultures examined by phase-con-
trast microscopy and trypan dye exclusion appeared perfectly
FIGURE 9
￿
Immunofluorescence distribution of the 22MÁ2 antigen
in confluent cells . PtK 2 (a and c) and BHK-21 (b and d) cells were
cultured at 100% confluence in MEM + 10% FCS (a and b) or
<25% confluence in MEM + 0.1% FCS (c and d) and were fixed
and processed for22MÁ2 immunofluorescence as described in the
text . Both cell types display negative immunofluorescent staining
of nuclei at 100% confluence (a and b), but they show positively
stained nuclei at subconfluence even in the presence of low serum
(c and d) . Bars, 20 tem . (a and c) x 300; (b and d) x 550 .
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FIGURE 10 Quantitative correlation of cell density with 22MÁ2
nuclear staining. BHK-21 coverslip cultures were grown at various
densities for 24-48 h and then fixed and processed for 22MÁ2
immunofluorescence . Each specimen was then tallied for total cells
in each area examined by phase-contrast microscopy (usually 5
mm 2 per area counted) and also for the number of cells displaying
positively stained nuclei in that same area as seen with fluorescence
optics . Results are expressed as total cells counted per square
millimeter (abscissa) vs . percentage of cells displaying positive flu-
orescent nuclei (ordinate) .
viable and healthy (results are not shown here) . This experi-
ment also was carried out using 3T3, BRL-3A, WI-38, and
HeLa cells and the results were the same as those shown in
Fig. 9 for PtK2 and BHK-21 cells. Fig . 9, c and d shows that
cells plated sparsely in medium containing low serum for up
to 72 h still display positive nuclear fluorescence with the
22MÁ2 antibody . Taken together these results suggest that
the absence of nuclear fluorescence is correlated with high cell
density rather than depletion of the growth medium .
Growth curve experiments were then carried out to deter-
mine whether the 22MÁ2 nuclear fluorescence was correlated
with cell density at various stages ofculture confluence . BHK-
21 cells were plated at various densities and allowed to grow
for 24-48 h . Coverslips were then fixed and processed for
22MÁ2 fluoresence, and quantitative counts were taken of
the percentages ofcells displaying positively fluorescent nuclei
as a function of cell density . Fig. 10 shows that almost 100%
of BHK-21 cells display positive nuclear fluorescence at low
densities, but that the percentage of positive nuclei gradually
declines as the cells grow to confluence . At confluence, the
nuclei are no longer stained by the antibody . This same
general phenomenon was observed in all the other cell lines
used in this type of study, and the results indicate that the
percentage of cells showing positive nuclear fluorescence is
inversely proportional to the density of the cell culture.
DISCUSSION
Hybridoma antibodies have proved to be invaluable as a
means of "fishing" for previously unidentified molecules that
are associated with specific cellular functions, and especially
for molecules for which no purification method exists (for
review see reference 11) . The present report, using a combi-
nation of existing methodologies, outlines a procedure
whereby monoclonal antibodies can be produced against spe-
cific molecules associated with the mitotic apparatus of cul-
tured mammalian cells. In our hands this experimental ap-
proach has produced several monoclonal antibodies ofpartic-
ular interest .
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mediately boiled in electrophoresis sample buffer before stor- 90
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0Because the immunizations in this study consisted ofHeLa
(human) spindles and the hybridomas were screened using
fixed PtK2 (marsupial) cells, this procedure selects for those
antibodies that are likely to cross-react with their specific
antigens in a wide variety of mammalian species. This is in
contrastto the results ofother investigators who have prepared
antibodies against MAPS or spindle components (also using
extracts from human cells) that recognize only human and/
or primate forms of the antigens (5, 12, 13, 18). However,
while our procedure selects for antibodies that might be more
utilitarian for a variety of purposes, it could also have the
drawback that in the screening procedure some desirable
hybridomas might go undetected because they produce anti-
body that reacts only with the human form ofthe antigen.
In this report we have described the production ofa partic-
ular monoclonal antibody and its use in the characterization
of a somewhat unusual putative microtubule-associated pro-
tein. The possibility that this antigen is an MAP is supported
by results that show that the 22MA2 monoclonal antibody
intracellularly co-localizes with both mitotic spindles and (to
a lesser extent) cytoplasmic microtubules, and that this distri-
bution is colcemid sensitive. It is also shown that the antibody
immunofluorescently stains the nuclei of interphase cells in
the exponential growth phase. The results ofthe fixation tests
suggest that methanol is an inferior fixative with regard to the
22MA2 antigen, and could lead to the possible misinterpre-
tation that the 22MA2 antigen is a strictly spindle-specific
MAP. We cannot make this conclusion because of the slight
but distinct staining of cytoplasmic microtubules with the
aldehyde fixation methods. The immunofluorescent images
seen using the 22MA2 antibody with methanol-fixed cells are
somewhat similar to those reported by other investigators (12)
using an antibody against a 200,000-mol-wt HeLa MAP in
immunofluorescence procedures also using methanol-fixed
cells. In that study the authors suggested that the 200,000-
mol-wt MAP is a spindle-specific component, but did not
indicate whether the same staining pattern was observed using
different fixation methods.
The present report also shows that the 22MA2 antibody
recognizes a single 240,000-mol-wt polypeptide whose relative
distribution in subcellular extracts agrees with the results of
the immunofluorescence studies. In this regard, the antibody
could be recognizing a similar determinant on two function-
ally unrelated molecules which happen to have the same
molecular weight. While such a series of coincidences is not
inconceivable, it seems highly improbable. In this study, we
have also shown that the antibody recognizes the 240,000-
mol-wt polypeptide in extracts from various cellsranging from
marsupial to human. Here the results again agree with the
immunofluorescence studies, in that the antibody recognizes
an antigenic determinant that appears to have been conserved
through the course of mammalian evolution .
Investigators using various methods have reported the iden-
tification of a number of mammalian non-neuronal MAPs in
the molecular weight range of 200,000-300,000 (4, 12, 13,
24, 33). The absence of the 240,000-mol-wt MAP in micro-
tubule proteins prepared by assembly/disassembly methods
(4, 24, 33) could be because it does not co-assemble with
microtubules in vitro, or because the elevated temperatures
required for microtubule assembly in vitro may result in the
proteolytic degradation of the 240,000-mol-wt MAP. The
latter possibility is very likely in view ofthe proteolysis studies
presented here. Whether any ofthe previously reported MAPs
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mightbe proteolytic fragments ofthe 240,000-mol-wt protein
described in the present study (or vice versa) cannot be
ascertained from the present data. Vallee and Bloom (32)
have recently identified a 235,000-mol-wt spindle-associated
MAP in extracts from sea urchin eggs, but their data do not
indicate the nature or distribution ofthis antigen in other cell
types. Further studies in this area might reveal some interest-
ing relationships between the various high molecular weight
MAPs which have been reported.
Investigators have previously speculated that certain factors
involved in mitotic spindle functions might be sequestered
within the nucleus ofcells during interphase (27). More recent
studies have identified specific nonchromosomal proteins
which appear to be associated with the mitotic apparatus and
the interphase nucleus (12, 18). Leyderson and Pettijohn (18)
identified a 300,000-mol-wt protein which is associated with
the nuclear matrix during interphase and the poles of the
mitotic apparatus during mitosis. Izant et al. (12) provided
evidence for a 200,000-mol-wt MAP which is associated with
interphase nuclei and mitotic spindle fibers. Thus evidence is
accumulating that suggests that a general class of spindle-
associated proteins/regulatory factors exists which are seques-
tered (at least to some extent) within the nucleus until needed
during cell division. The results of our biochemical and
immunocytochemical analyses suggest that the 240,000-mol-
wt 22MA2 antigen may be included in such a classofproteins.
An intriguing characteristic of the protein seen in the pres-
ent report is that it is no longer detectable in the nuclei of
confluent cells by immunofluorescence using the 22MA2
antibody. Several possible reasons for this phenomenon can
be envisioned, among which are: (a) the protein may no
longer be sequestered in nuclei; (b) the protein may undergo
modification at the 22MA2 antibody binding site, or (c) the
protein may become complexed with another macromolecule
at the antibody binding site. Any of these phenomena could
be occurring in response to cellular processes/signals involved
in the density-dependent "turning off" of a cell with respect
to its immediate potential for replication . This is, however,
no more than speculation derived from general observations.
The possible function ofthe 240,000-mol-wt protein can only
be elucidated through further study. Nevertheless, the possi-
bility that this protein changes (with regard to either distri-
bution, structure, or association with other molecules) in
response to the cell's potential for growth/division is poten-
tially very interesting. Whatever the reason for the phenom-
enon, the search for its cause ideally might lead to new data
regarding the mechanisms that determine the division poten-
tial of the cell. For this reason, we are currently engaged in a
variety of studies toward this end.
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